无菌取样市场 - 全球产业规模、份额、趋势、机会及预测（按类型、技术、应用、最终用途、地区和竞争格局划分，2021-2031年）

全球无菌采样市场预计将从 2025 年的 9.8332 亿美元成长到 2031 年的 15.4401 亿美元，复合年增长率为 7.81%。

无菌取样是指在不破坏样本或原料无菌性的前提下，从无菌生产容器或生产线上精确取出样本的过程。这项关键流程的实施源自于全球对生物製药和疫苗日益增长的需求，这些产品需要严格的GMP标准和严格的污染控制。随着产量的增加，为确保病患安全，频繁且可靠的无菌检测的需求也随之成长。根据国际药品製造商协会联合会（IFPMA）的数据，到2024年，全球将有超过9,000种化合物处于不同的研发阶段，凸显了在整个药品研发和生产生命週期中，严谨的品质保证机制至关重要。

然而，由于先进采样技术的实施成本高昂，市场面临严峻的挑战。将一次性或自动化采样系统整合到现有不銹钢设备中所需的资本投入可能非常巨大，尤其对于利润率较低的中小型契约製造而言更是如此。这个财务障碍，加上维修现有基础设施的技术复杂性以及对操作人员进行专业培训的需求，使得这些关键安全解决方案在成本敏感地区难以广泛应用。

市场驱动因素

药物研发投入的增加，正透过资助下一代生产设施的建设，从根本上改变全球无菌取样格局。随着製造商扩大生产规模以满足复杂治疗方法的需求，安装可靠的取样点对于维持製程完整性至关重要。这笔资金的涌入扩大了无菌生产场所的物理规模，从而即时催生了对先进取样阀和一次性组件的需求，以便在不影响无菌性的前提下监测关键程式参数。例如，礼来公司在2024年5月的新闻稿中宣布，将追加投资53亿美元以提升其活性药物​​成分的生产能力。此举需要大规模整合无污染监测系统。如此大规模的产能扩张将推动自动化取样技术的应用，从而最大限度地减少人为干预，并确保批次一致性。

对污染控制和风险缓解的日益重视进一步加速了这些系统的应用，尤其是在註射剂领域，无菌性至关重要。传统的人工取样方法日益被视为一个重要的风险因素，促使产业转向将製程与环境隔离的封闭式系统解决方案。随着监管机构不断核准需要严格环境监测的高价值生物製药产品，这种转变至关重要。美国食品药物管理局(FDA) 确认将于 2024 年核准55 种新型疗法，显示越来越多的高敏感性产品正在进入市场。为了支持这一成长，製造商正在大力投资专业的填充和包装基础设施。例如，诺和诺德在 2024 年 6 月宣布计划投资 41 亿美元扩大其无菌填充和包装产能，这将直接影响对可靠无菌检测机制的需求。

市场挑战

先进无菌取样技术所需的大量资本投入是限制市场扩张的主要阻碍因素。使用传统不銹钢设备的製造商在尝试以现代自动化或一次性取样介面改造现有系统时，往往面临高昂的成本。对于流动资金有限的中小型契约製造组织 (CMO) 而言，这种财务负担尤其沉重。在升级基础设施和维持现有手动操作流程之间，成本限制迫使这些公司推迟现代化改造，从而限制了新型取样设备的潜在市场。

这种经济压力因製药业的整体资本需求而进一步加剧，该产业的资源分配严重偏向核心研发活动。据美国药品研究与製造商协会（PhRMA）称，其成员公司报告称，到2024年，研发总支出约为1,030亿美元。如此庞大的支出规模凸显了生命科学公司内部对资本资源的激烈竞争。由于可用资金优先用于药物发现和临床试验，用于升级二级生产设施的预算受到限制。因此，这些安全解决方案的采用率正在放缓，直接阻碍了全球无菌取样市场的整体成长。

市场趋势

细胞和基因疗法生产的客製化正在重塑市场格局，这需要专门的小容量取样解决方案。与传统生物製药不同，自体疗法处理的是珍贵的患者特异性材料，因此无法进行大规模萃取。这就需要能够进行微升级取样且不影响批次产量的闭合迴路系统。先进治疗方法专用设施的激增直接推动了这些精准技术的应用。例如，根据《製药业评论》2025年5月报道，Astra Zeneca在美国罗克维尔正式启用了一座价值3亿美元的T细胞疗法新设施，这催生了对用于下一代生产的专用取样设备的需求。

为了确保资料完整性并加快批次放行速度，采样资料正日益数位化并与实验室资讯管理系统 (LIMS) 整合。製造商正在用自动化数位工作流程取代人工记录，这些工作流程能够同步实体采样和分析数据，从而减少人为错误。这一转变是由对「製药4.0」数位基础设施的投资所驱动的。正如Thomasnet在2025年8月的一篇报导中所述，罗克韦尔自动化公司已承诺投资20亿美元，用于透过数位系统增强製造能力，这反映出整个产业正积极推进资料架构现代化，以支援品管流程。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球无菌取样市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（人工采样、自动采样）
  • 按技术（离线采样技术、线上采样技术、在线连续采样技术）
  • 依应用领域（下游製程、上游工程）
  • 按最终用途（製药/生物技术公司、合约生产商/合约研究机构、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美无菌取样市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲无菌取样市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区无菌取样市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲无菌取样市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲无菌取样市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球无菌取样市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Sartorius AG
• Eppendorf SE
• Lonza Group Ltd.
• GEA Group Aktiengesellschaft
• Keofitt A/S
• QualiTru Sampling Systems
• WL Gore & Associates, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Aseptic Sampling Market is projected to expand from USD 983.32 Million in 2025 to USD 1544.01 Million by 2031, registering a CAGR of 7.81%. Aseptic sampling involves the precise extraction of samples from sterile manufacturing vessels or processing lines without compromising the sterility of either the sample or the bulk material. This critical procedure is fueled by the rising global demand for biologics and vaccines, which require strict adherence to Good Manufacturing Practice (GMP) standards and rigorous contamination control. As production volumes grow, the need for frequent and reliable sterility testing to ensure patient safety increases proportionately. Data from the International Federation of Pharmaceutical Manufacturers and Associations indicates that in 2024, over 9,000 compounds were in various stages of development globally, highlighting the significant operational necessity for precise quality assurance mechanisms throughout the drug development and manufacturing lifecycle.

However, the market encounters a major challenge due to the high implementation costs of advanced sampling technologies. The capital investment needed to integrate single-use or automated sampling systems into legacy stainless steel facilities can be prohibitive, especially for smaller contract manufacturing organizations operating on thin margins. This financial barrier, along with the technical complexity of retrofitting existing infrastructure and the requirement for specialized operator training, creates substantial friction that may hinder the broader adoption of these essential safety solutions in cost-sensitive regions.

Market Driver

Rising investments in pharmaceutical research and development are fundamentally reshaping the global aseptic sampling landscape by funding the construction of next-generation manufacturing facilities. As manufacturers scale up production to handle complex therapeutic modalities, the installation of robust sampling points becomes essential for maintaining process integrity. This capital influx expands the physical footprint of sterile manufacturing sites, creating an immediate need for advanced sampling valves and single-use assemblies to monitor critical process parameters without breaching sterility. For example, Eli Lilly and Company announced in a May 2024 press release an additional $5.3 billion commitment to enhance active pharmaceutical ingredient production, a move that necessitates the extensive integration of contamination-free monitoring systems. Such large-scale capacity enhancements drive the adoption of automated sampling technologies to minimize human intervention and ensure batch consistency.

A heightened focus on contamination control and risk mitigation further accelerates the adoption of these systems, particularly for injectable treatments where sterility is paramount. Conventional manual sampling methods are increasingly viewed as critical risk points, pushing the industry toward closed-system solutions that isolate the process stream from the environment. This shift is essential as regulatory bodies continue to approve high-value biologics that require stringent environmental monitoring. The U.S. Food and Drug Administration confirmed the approval of 55 novel therapeutics in 2024, underscoring the influx of sensitive products entering the market. To support this growth, manufacturers are heavily investing in specialized fill-finish infrastructure; for instance, Novo Nordisk announced plans in June 2024 to invest $4.1 billion to expand aseptic fill and finish capacity, directly influencing the demand for reliable sterility testing mechanisms.

Market Challenge

The substantial capital investment required for advanced aseptic sampling technologies acts as a primary restraint on market expansion. Manufacturers operating legacy stainless steel facilities often face prohibitive costs when attempting to retrofit these systems with modern automated or single-use sampling interfaces. This financial burden is particularly acute for small and medium-sized contract manufacturing organizations that operate with limited liquidity. When faced with the choice of upgrading infrastructure or maintaining existing manual procedures, cost constraints often force these entities to defer modernization, thereby limiting the addressable market for new sampling devices.

This economic pressure is compounded by the broader financial demands of the pharmaceutical sector, where resource allocation is heavily skewed toward core development activities. According to the Pharmaceutical Research and Manufacturers of America, member companies reported research and development expenditures totaling roughly $103 billion in 2024. This magnitude of spending highlights the intense competition for capital resources within life sciences organizations. When available funds are prioritized for drug discovery and clinical trials, the budget for secondary manufacturing upgrades becomes restricted. Consequently, the adoption rate of these safety solutions slows, directly impeding the overall growth trajectory of the global aseptic sampling market.

Market Trends

Customization for cell and gene therapy manufacturing is reshaping the market by demanding specialized, low-volume sampling solutions. Unlike traditional biologics, autologous therapies process precious patient-specific materials where large-volume extraction is unfeasible. This necessitates closed-loop systems capable of withdrawing microliter volumes without compromising batch yield. The surge in dedicated facilities for advanced therapies directly fuels the adoption of these precision technologies. For instance, according to a May 2025 article in Pharma Industry Review, AstraZeneca officially opened a new $300 million facility in Rockville, USA, for T-cell therapies, creating operational demand for specialized sampling mechanisms in next-generation production.

The digitization of sampling data and LIMS integration is advancing to ensure data integrity and accelerate batch release. Manufacturers are replacing manual logs with automated digital workflows that synchronize physical sampling with analytical data, mitigating human error. This transition is propelled by investments in "Pharma 4.0" digital infrastructure. As noted in an August 2025 Thomasnet article, Rockwell Automation committed $2 billion to enhance its manufacturing with digital systems, reflecting the sector's aggressive move to modernize the data architecture underpinning quality control procedures.

Key Market Players

• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Sartorius AG
• Eppendorf SE
• Lonza Group Ltd.
• GEA Group Aktiengesellschaft
• Keofitt A/S
• QualiTru Sampling Systems
• W. L. Gore & Associates, Inc.

Report Scope

In this report, the Global Aseptic Sampling Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Aseptic Sampling Market, By Type

• Manual Sampling
• Automated Sampling

Aseptic Sampling Market, By Technique

• Off-line Sampling Technique
• On-line Sampling Technique
• In-line Sampling Technique

Aseptic Sampling Market, By Application

• Downstream Processing
• Upstream Processing

Aseptic Sampling Market, By End Use

• Pharmaceutical & Biotechnology Companies
• CMOs & CROs
• Others

Aseptic Sampling Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Aseptic Sampling Market.

Available Customizations:

Global Aseptic Sampling Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Aseptic Sampling Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Manual Sampling, Automated Sampling)
  • 5.2.2. By Technique (Off-line Sampling Technique, On-line Sampling Technique, In-line Sampling Technique)
  • 5.2.3. By Application (Downstream Processing, Upstream Processing)
  • 5.2.4. By End Use (Pharmaceutical & Biotechnology Companies, CMOs & CROs, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Aseptic Sampling Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Aseptic Sampling Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada Aseptic Sampling Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico Aseptic Sampling Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End Use

7. Europe Aseptic Sampling Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Aseptic Sampling Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End Use
  • 7.3.2. France Aseptic Sampling Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom Aseptic Sampling Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Aseptic Sampling Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Aseptic Sampling Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End Use

8. Asia Pacific Aseptic Sampling Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Aseptic Sampling Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Aseptic Sampling Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan Aseptic Sampling Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea Aseptic Sampling Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Aseptic Sampling Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End Use

9. Middle East & Africa Aseptic Sampling Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Aseptic Sampling Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE Aseptic Sampling Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa Aseptic Sampling Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End Use

10. South America Aseptic Sampling Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Aseptic Sampling Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia Aseptic Sampling Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina Aseptic Sampling Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Aseptic Sampling Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Danaher Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. Merck KGaA
• 15.4. Sartorius AG
• 15.5. Eppendorf SE
• 15.6. Lonza Group Ltd.
• 15.7. GEA Group Aktiengesellschaft
• 15.8. Keofitt A/S
• 15.9. QualiTru Sampling Systems
• 15.10. W. L. Gore & Associates, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer